Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis.

Autor: Vincelette ND; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida., Yu X; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center & Research Institute, Tampa, Florida., Kuykendall AT; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida., Moon J; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida., Su S; Department of Chemistry, University of Illinois Chicago, Chicago, Illinois., Cheng CH; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center & Research Institute, Tampa, Florida., Sammut R; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida.; Département d'Hématologie Clinique, Centre Hospitalier Universitaire de Nice, Nice, France., Razabdouski TN; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida., Nguyen HV; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia., Eksioglu EA; Department of Immunology, Moffitt Cancer Center & Research Institute, Tampa, Florida., Chan O; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida., Al Ali N; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida., Patel PC; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida.; Department of Internal Medicine, University of South Florida, Tampa, Florida., Lee DH; Division of Cardiovascular Science, Department of Internal Medicine, University of South Florida, Tampa, Florida., Nakanishi S; Department of Tumor Microenvironment & Metastasis, Moffitt Cancer Center & Research Institute, Tampa, Florida., Ferreira RB; Department of Drug Discovery, Moffitt Cancer Center & Research Institute, Tampa, Florida., Hyjek E; Department of Pathology and Laboratory Medicine, Moffitt Cancer Center & Research Institute, Tampa, Florida., Mo Q; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center & Research Institute, Tampa, Florida., Cory S; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia., Lawrence HR; Department of Drug Discovery, Moffitt Cancer Center & Research Institute, Tampa, Florida., Zhang L; Department of Pathology and Laboratory Medicine, Moffitt Cancer Center & Research Institute, Tampa, Florida., Murphy DJ; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.; Cancer Research UK Scotland Institute, Glasgow, United Kingdom., Komrokji RS; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida., Lee D; Department of Chemistry, University of Illinois Chicago, Chicago, Illinois., Kaufmann SH; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota.; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Cleveland JL; Department of Tumor Microenvironment & Metastasis, Moffitt Cancer Center & Research Institute, Tampa, Florida., Yun S; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida.

Publikováno v: Blood cancer discovery [Blood Cancer Discov] 2024 Jul 01; Vol. 5 (4), pp. 276-297.